2.2011
trends in automation
Synergies/Festo worldwide
42
–
43
Switzerland
High over Lake Geneva with a view of the grand
panorama of the French Alps one of the most
remarkable biotech facilities in the world is
emerging: the Merck Serono Biotech Center. This
is where, from 2012, the cancer treatment product
Erbitux will be produced using reliable automation
technology from Festo.
Festo supplied 200 ready-to-install stainless steel
control cabinets for the approximately 80 preparation
vessels and bioreactors in the new biotech factory
with around 5000 valve functions. The core of the
automation process at sensor actuator level is the
valve terminal CPX/MPA. Thanks to its flexible design
any non fieldbus-capable signals and process valves
are connected to the bus controlled valve terminal as
an I/O component.
Completely pre-assembled and tested, Festo’s ready-
to-install system solution was delivered directly to
the plant and came with all the construction data
and wiring diagrams. Thanks to standardised
automation technology, biotechnology for Merck
Serono will become a really promising production
technology – not only at sites such as this one, high
above Lake Geneva.
www.merckserono.com
Good outlook all round
Ready-to-install control cabinets set standards
A control cabinet as a complete solution:
The core of the
automation process at sensor actuator level is the valve
terminal CPX/MPA.
A combination with a promising future:
Bioreactors and
automation technology with valve terminals CPX/MPA from
Festo in the control cabinet supplied ready to install.
Merck Serono on Lake Geneva:
A site with the best outlook for biotechnology.